Indicator Explainer
Gastrin-Releasing Peptide
Gastrin-releasing peptide (27 aa, ~3 kDa) is encoded by the human GRP gene. This protein is involved in hormone signaling in both the gastrointestinal and nervous systems.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C2272. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-20. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — Gastrin-Releasing Peptide (C2272)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C2272. NCI definition, reproduced without modification under CC BY 4.0.
- Gastrin-releasing peptide, neuromedin B, and symptom severity in adult attention-deficit hyperactivity disorder. — Rev Assoc Med Bras (1992), 2026-10-12 (PMID 42879589; literature)
- Blockade of gastrin-releasing peptide receptor in the PVN alleviates maternal vascular and placental dysfunction in preeclamptic rat. — Int Immunopharmacol, 2026-10-08 (PMID 42849119; literature)
- Gastrin and cholecystokinin 2 receptor, and gastrin-releasing peptide receptor in cancer: From pathogenesis to precision medicine. — Biomed Pharmacother, 2026-10-05 (PMID 42833072; literature)
- Novel dual-targeted gastrin-releasing peptide receptor and fibroblast activation protein radiopharmaceuticals for molecular imaging of heterogeneous breast tumors. — Eur J Pharm Sci, 2026-08-23 (PMID 42633805; literature)
- An indocyanine green-potentiated gastrin releasing peptide receptor-targeting multifunctional peptide-drug conjugate for prostate cancer therapy. — J Control Release, 2026-08-16 (PMID 42604690; literature)